What evidence supports the administration of IV fluids concurrently with IV Gemcitabine?
Abstract
IV fluid administration is commonly used with chemotherapy to maintain hydration, though specific studies on concurrent administration with Gemcitabine are limited, primarily noted for mitigating renal toxicity in combination regimens.
Fields of Study & Subjects
Chemotherapy-induced organ toxicity mitigation
Cancer Treatment and Pharmacology
Chemotherapy-related skin toxicity
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 30 January 2026